Brain DA D2 receptors predict reinforcing effects of stimulants in humans: replication study
- PMID: 12211085
- DOI: 10.1002/syn.10137
Brain DA D2 receptors predict reinforcing effects of stimulants in humans: replication study
Erratum in
- Synapse. 2003 Mar 15;47(4):295.. Thanos Pether [corrected to Thanos Panayotis Peter K]
Abstract
We had shown that striatal DA D2 receptors levels predicted the reinforcing responses to the psychostimulant drug methylphenidate in nondrug-abusing subjects. Here, we assessed the replicability of this finding. We measured D2 receptors with PET and [(11)C]raclopride (twice to determine stability) in seven nondrug-abusing subjects to assess if they predicted the self-reports of "drug-liking" to intravenous methylphenidate (0.5 mg/kg). DA D2 measures were significantly correlated with "drug-liking" in both evaluations (r = 0.82 and r = 0.78); subjects with the lowest levels reported the higher ratings of "drug-liking" and vice versa. These results replicate our previous findings and provide further evidence that striatal DA D2 receptors modulate reinforcing responses to stimulants in humans and may underlie predisposition for drug self-administration.
Copyright 2002 Wiley-Liss, Inc.
Similar articles
-
PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys.Nat Neurosci. 2006 Aug;9(8):1050-6. doi: 10.1038/nn1737. Epub 2006 Jul 9. Nat Neurosci. 2006. PMID: 16829955
-
Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels.Am J Psychiatry. 1999 Sep;156(9):1440-3. doi: 10.1176/ajp.156.9.1440. Am J Psychiatry. 1999. PMID: 10484959
-
Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction.Am J Psychiatry. 1999 Jan;156(1):19-26. doi: 10.1176/ajp.156.1.19. Am J Psychiatry. 1999. PMID: 9892293
-
Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies.Behav Pharmacol. 2002 Sep;13(5-6):355-66. doi: 10.1097/00008877-200209000-00008. Behav Pharmacol. 2002. PMID: 12394411 Review.
-
Similarity between obesity and drug addiction as assessed by neurofunctional imaging: a concept review.J Addict Dis. 2004;23(3):39-53. doi: 10.1300/J069v23n03_04. J Addict Dis. 2004. PMID: 15256343 Review.
Cited by
-
Examination of reward processing dysfunctions in the left dorsal striatum and other brain regions among psychiatric inpatients with substance use.Drug Alcohol Depend. 2024 Mar 1;256:111097. doi: 10.1016/j.drugalcdep.2024.111097. Epub 2024 Jan 20. Drug Alcohol Depend. 2024. PMID: 38266574
-
Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention.World Psychiatry. 2023 Jun;22(2):203-229. doi: 10.1002/wps.21073. World Psychiatry. 2023. PMID: 37159360 Free PMC article.
-
Association of dopamine D2-like and D3 receptor function with initial sensitivity to cocaine reinforcement in male rhesus monkeys.Brain Res. 2023 May 15;1807:148323. doi: 10.1016/j.brainres.2023.148323. Epub 2023 Mar 11. Brain Res. 2023. PMID: 36914041 Free PMC article.
-
The Effects of the Inhalant Toluene on Cognitive Function and Behavioral Flexibility: A Review of Recent Findings.Addict Neurosci. 2023 Mar;5:100059. doi: 10.1016/j.addicn.2022.100059. Epub 2022 Dec 22. Addict Neurosci. 2023. PMID: 36798693 Free PMC article.
-
A mechanistic overview of approaches for the treatment of psychostimulant dependence.Front Pharmacol. 2022 Sep 8;13:854176. doi: 10.3389/fphar.2022.854176. eCollection 2022. Front Pharmacol. 2022. PMID: 36160447 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources